Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

621 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF Registry.
Paquette M, França LR, Teutsch C, Diener HC, Lu S, Dubner SJ, Ma CS, Rothman KJ, Zint K, Halperin JL, Olshansky B, Huisman MV, Lip GYH, Nieuwlaat R. Paquette M, et al. Among authors: ma cs. Am J Cardiol. 2020 Feb 1;125(3):383-391. doi: 10.1016/j.amjcard.2019.10.047. Epub 2019 Nov 7. Am J Cardiol. 2020. PMID: 31785775 Free article. Clinical Trial.
Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation?: a meta-analysis.
D'Ascenzo F, Corleto A, Biondi-Zoccai G, Anselmino M, Ferraris F, di Biase L, Natale A, Hunter RJ, Schilling RJ, Miyazaki S, Tada H, Aonuma K, Yenn-Jiang L, Tao H, Ma C, Packer D, Hammill S, Gaita F. D'Ascenzo F, et al. Int J Cardiol. 2013 Sep 1;167(5):1984-9. doi: 10.1016/j.ijcard.2012.05.008. Epub 2012 May 22. Int J Cardiol. 2013. PMID: 22626840 Free article.
Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation.
Huisman MV, Lip GY, Diener HC, Dubner SJ, Halperin JL, Ma CS, Rothman KJ, Teutsch C, Zint K, Ackermann D, Clemens A, Bartels DB. Huisman MV, et al. Among authors: ma cs. Am Heart J. 2014 Mar;167(3):329-34. doi: 10.1016/j.ahj.2013.12.006. Epub 2013 Dec 19. Am Heart J. 2014. PMID: 24576516
Rationale and design of the eXplore the efficacy and safety of once-daily oral riVaroxaban for the prEvention of caRdiovascular events in patients with nonvalvular aTrial fibrillation scheduled for cardioversion trial: A comparison of oral rivaroxaban once daily with dose-adjusted vitamin K antagonists in patients with nonvalvular atrial fibrillation undergoing elective cardioversion.
Ezekowitz MD, Cappato R, Klein AL, Camm AJ, Ma CS, Le Heuzey JY, Talajic M, Scanavacca MI, Vardas PE, Kirchhof P, Hohnloser SH, Hemmrich M, Lanius V, Meng IL, Wildgoose P, van Eickels M. Ezekowitz MD, et al. Among authors: ma cs. Am Heart J. 2014 May;167(5):646-52. doi: 10.1016/j.ahj.2013.12.024. Epub 2014 Jan 14. Am Heart J. 2014. PMID: 24766973 Clinical Trial.
Catheter ablation of atrial fibrillation in patients with rheumatoid arthritis.
Wen SN, Liu N, Li SN, Salim M, Yan Q, Wu XY, Wang Y, Kang JP, Ning M, Wu JH, Ruan YF, Yu RH, Long DY, Tang RB, Sang CH, Jiang CX, Bai R, Hu R, Du X, Dong JZ, Liu XH, Ma CS. Wen SN, et al. Among authors: ma cs. J Cardiol. 2015 Oct;66(4):320-5. doi: 10.1016/j.jjcc.2014.12.003. Epub 2015 Jan 9. J Cardiol. 2015. PMID: 25583089 Free article.
621 results